Erratum to: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

首页> 外文期刊>Annals of Surgical Oncology >Erratum to: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

【24h】

Erratum to: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

机译：勘误：为何必须采取细胞减缩术加高温腹膜内化疗作为弥漫性恶性腹膜间皮瘤治疗新标准的五个原因

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of Surgical Oncology》 |2011年第s3期|p.328-328|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Five Reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal. [J] . Sugarbaker PH Annals of surgical oncology . 2010,第6期

机译：必须将细胞减灭术加腹膜内高温化疗作为弥漫性恶性腹膜护理的新标准的五个原因。
2. The Role of Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy [J] . Marcello Deraco, Dario Baratti, Ionut Hutanu, Annals of surgical oncology . 2013,第4期

机译：围手术期全身化学疗法在弥漫性恶性腹膜间皮瘤患者中的应用细胞减少手术和高温腹膜内化学疗法的作用
3. Erratum: Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin [J] . Annals of Surgical Oncology . 2011,第s3期

机译：勘误：腹腔内高温化学疗法用于恶性腹膜间皮瘤的细胞减少手术：丝裂霉素与顺铂
4. Intraperitoneal Chemotherapy for the Treatment of Malignant Peritoneal Mesothelioma. [D] . Leinwand, Joshua Caleb. 2013

机译：腹膜内化学疗法治疗恶性腹膜间皮瘤。
5. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma [O] . Aaron U. Blackham, Edward A. Levine -1

机译：细胞减灭术用温热腹腔化疗治疗恶性腹膜间皮瘤
6. Erratum to: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study [O] . J. Hommell-Fontaine, S. Isaac, G. Passot, 2014

机译：错误到：细胞术手术和高温腹膜内化疗治疗恶性腹膜间皮瘤：是Glut1表达主要的预后因子吗？初步研究

Erratum to: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

著录项

相似文献

相关主题

期刊订阅